3037 — Unimicron Technology Balance Sheet
0.000.00%
Last trade - 00:00
- TWD278.10bn
- TWD260.27bn
- TWD104.04bn
- 59
- 27
- 93
- 66
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Cash | |||||
Cash and Equivalents | |||||
Short Term Investments | |||||
Cash and Short Term Investments | 20,606 | 24,226 | 39,451 | 61,496 | 52,948 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 18,325 | 18,587 | 25,721 | 30,514 | 19,497 |
Total Inventory | |||||
Prepaid Expenses | |||||
Total Other Current Assets | |||||
Total Current Assets | 49,962 | 53,731 | 79,877 | 107,588 | 86,579 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 52,252 | 60,493 | 75,162 | 96,856 | 112,345 |
Net Goodwill | |||||
Net Intangible Assets | |||||
Long Term Investments | |||||
Other Long Term Assets | |||||
Total Assets | 110,202 | 124,710 | 170,055 | 218,663 | 216,006 |
Accounts Payable | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 36,206 | 42,369 | 49,060 | 54,893 | 44,247 |
Long Term Debt | |||||
Capital Lease Obligations | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Deferred Income Tax | |||||
Minority Interest | |||||
Total Other Liabilities | |||||
Total Funded Status | |||||
Total Liabilities | 66,310 | 76,283 | 109,342 | 132,929 | 125,345 |
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Treasury Stock | |||||
Unrealized Gain / Loss | |||||
Other Equity | |||||
Total Equity | 43,892 | 48,427 | 60,714 | 85,735 | 90,661 |
Total Liabilities & Shareholders' Equity | 110,202 | 124,710 | 170,055 | 218,663 | 216,006 |
Total Common Shares Outstanding |